{"id":"W2163188114","doi":"10.1093/annonc/mdl165","title":"Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Microbial Natural Products and Biosynthesis","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Northeast Cancer Centre; Université de Montréal; Hôpital Notre-Dame; Children's Hospital of Eastern Ontario; Ottawa Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Rash; Nausea; Adverse effect; Vomiting; myalgia; Mucositis; Internal medicine; Phases of clinical research; Progressive disease; Gastroenterology; Toxicity; Lung cancer; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003765677,0.0001797621,0.00160312,0.0003808538,0.00002610096,0.000002718155,0.0001439045,0.000130846,0.00006534604],"category_scores_gemma":[0.00134579,0.0001270921,0.00006414924,0.0005267246,0.00009016356,0.0000930334,0.00006463359,0.0002940244,1.878793e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002382856,"about_ca_system_score_gemma":0.002347024,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1635086,"about_ca_topic_score_gemma":0.5680266,"domain_scores_codex":[0.9962518,0.0006352582,0.001851066,0.0003621921,0.0006581179,0.0002415761],"domain_scores_gemma":[0.9976133,0.0003603849,0.000878745,0.000212956,0.0008481797,0.00008646607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09327543,0.07427521,0.7019393,0.0001209337,0.0005573326,0.00009979532,0.001308272,0.0001459906,0.02050682,0.000008624311,0.009491511,0.0982708],"study_design_scores_gemma":[0.03749464,0.05782298,0.8935692,0.0002931749,0.00006567982,8.513051e-7,0.0004332289,0.000002606839,0.005416477,0.000016896,0.004716497,0.000167775],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960355,0.0001598792,5.767517e-7,0.001099272,0.0002213773,0.00224761,0.0001549465,0.000003950983,0.00007684152],"genre_scores_gemma":[0.9991148,0.0000719194,0.00005497174,0.0005192414,0.0001540748,0.00001595095,0.00002535568,0.00001350336,0.0000302217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.404518,"threshold_uncertainty_score":0.8420616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1319914723872837,"score_gpt":0.4477888923124596,"score_spread":0.3157974199251758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}